Urofacial syndrome: A genetic and congenital disease of aberrant urinary bladder innervation

Pediatric Nephrology

Volumn 29, Issue 4, 2014, Pages 513-518

  Woolf, Adrian S ^a   Stuart, Helen M ^a   Roberts, Neil A ^a   McKenzie, Edward A ^a   Hilton, Emma N ^a   Newman, William G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autonomic; Bladder; Detrusor; Fetus; Heparanase; Nerve

Indexed keywords

GROWTH FACTOR; HEPARAN SULFATE; HEPARANASE; HEPARANASE 1; HEPARANASE 2; LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAIN 2; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

AUTONOMIC NERVE; BLADDER CONTRACTION; BLADDER DYSFUNCTION; CONFERENCE PAPER; CONGENITAL DISORDER; CRYING; DETRUSOR MUSCLE; END STAGE RENAL DISEASE; ENZYME ACTIVITY; FACIAL EXPRESSION; FETUS BLADDER; GENETIC DISORDER; HUMAN; HYPOTHESIS; IMPAIRED BLADDER EMPTYING; NERVE CELL GROWTH; NEUROGENIC BLADDER; NONHUMAN; NONVERBAL COMMUNICATION; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; URINE INCONTINENCE; UROFACIAL SYNDROME; UROSEPSIS; VESICOURETERAL REFLUX;

FACIES; HUMANS; URINARY BLADDER; UROLOGIC DISEASES;

EID: 84896728597     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2552-2     Document Type: Conference Paper

References (44)

1. Morris RK, Malin GL, Khan KS, Kilby MD (2010) Systematic review of the effectiveness of antenatal intervention for the treatment of congenital lower urinary tract obstruction. BJOG 117:382-390
2. Farrugia MK, Woolf AS (2010) Congenital urinary bladder outlet obstruction. Fetal Maternal Med Rev 21:155-173
3. Woolf AS, Stuart HM, Newman WG (2013) Genetics of human congenital urinary bladder disease. Pediatr Nephrol. doi: 10.1007/s00467-013-2472-1
4. Wiesel A, Queisser-Luft A, Clementi M, Bianca S, Stoll C, EUROSCAN Study Group (2005) Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet 48:131-144
5. Ochoa B (2004) Can a congenital dysfunctional bladder be diagnosed from a smile? Pediatr Nephrol 19:6-12
6. Aydogdu O, Burgu B, Demirel F, Soygur T, Ozcakar ZB, Yalcinkaya F, Tekgul S (2010) Ochoa syndrome: a spectrum of urofacial syndrome. Eur J Pediatr 169:431-435
7. Daly SB, Urquhart JE, Hilton E, McKenzie EA, Kammerer RA, Lewis M, Kerr B, Stuart H, Donnai D, Long DA, Burgu B, Aydogdu O, Derbent M, Garcia-Minaur S, Reardon W, Gener B, Shalev S, Smith R, Woolf AS, Black GC, Newman WG (2010) Mutations in HPSE2 cause urofacial syndrome. Am J Hum Genet 11:963-969
8. Stuart HM, Roberts NA, Bergu B, Daly SB, Urquhart JE, Bhaskar S, Dickerson J, Mermerkaya M, Silay MS, Lewis MA, Olondriz BO, Gener B, Beetz C, Varga RE, GülpInar O, Süer E, YalçInkaya F, Gücük A, Yue WW, Erdogan F, Berry A, Hanley NA, McKenzie EA, Hilton EN, Woolf AS, Newman WG (2013) LRIG2 mutations cause urofacial syndrome. Am J Hum Genet 92:259-264
9. Benarroch EE (2010) Neural control of the bladder: recent advances and neurologic implications. Neurology 75:1839-1846
10. Gilpin SA, Gosling JA (1983) Smooth muscle in the wall of the developing human urinary bladder and urethra. J Anat 137:503-512
11. Jenkins D, Winyard PJ, Woolf AS (2007) Immunohistochemical analysis of Sonic hedgehog signalling in normal human urinary tract development. J Anat 211:620-629
12. Weber S, Thiele H, Mir S, Toliat MR, Sozeri B, Reutter H, Draaken M, Ludwig M, Altmüller J, Frommolt P, Stuart HM, Ranjzad P, Hanley NA, Jennings R, Newman WG, Wilcox DT, Thiel U, Schlingmann K-P, Beetz R, Hoyer PF, Konrad M, Schaefer F, Nürnberg P, Woolf AS (2011) Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome. Am J Hum Genet 89:668-674
13. Ganesan I, Thomas T (2011) More than meets the smile: facial muscle expression in children with Ochoa syndrome. Med J Malaysia 66:507-509
14. Pang J, Zhang S, Yang P, Hawkins-Lee B, Zhong J, Zhang Y, Ochoa B, Agundez JAG, Voelckel MA, Gu W, Xiong W-C, Mei L, She JX, Wang CY (2010) Loss-of-Function mutations in HPSE2 Cause the autosomal recessive urofacial syndrome. Am J Hum Genet 11:957-962
15. Al Badr W, Al Bader S, Otto E, Hildebrandt F, Ackley T, Peng W, Xu J, Li J, Owens KM, Bloom D, Innis JW (2011) Exome capture and massively parallel sequencing identifies a novel HPSE2 mutation in a Saudi Arabian child with Ochoa (urofacial) syndrome. J Pediatr Urol 7:569-573
16. Mahmood S, Beetz C, Tahir MM, Imran M, Mumtaz R, Bassmann I, Jahic A, Malik M, Nürnberg G, Hassan SA, Rana S, Nürnberg P, Hübner CA (2012) First HPSE2 missense mutation in urofacial syndrome. Clin Genet 81:88-92
17. McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M (2000) Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun 276:1170-1177
18. Levy-Adam F, Feld S, Cohen-Kaplan V, Steingaus A, Gross M, Arvatz G, Naroditsy I, Ilan N, Doweck I, Vlodavsky I (2010) Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. J Biol Chem 285:280-289
19. Arvatz G, Shafat I, Levy-Adam F, Ilan N, Vlodavsky I (2011) The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer Metastasis Rev 30:253-268
20. Levy-Adam F, Ilan N, Vlodavsky I (2010) Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol 20:153-160
21. Rodrigues LM, Theodoro TR, Matos LL, Mader AM, Milani C, Pinhal MA (2011) Heparanase isoform expression and extracellular matrix remodeling in intervertebral disc degenerative disease. Clinics (Sao Paulo) 66:903-909
22. Peretti T, Waisberg J, Mader AM, de Matos LL, da Costa RB, Conceição GM, Lopes AC, Nader HB, Pinhal MA (2008) Heparanase 2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma. Eur J Gastroenterol Hepatol 20:756-765
23. Wiese CB, Ireland S, Fleming NL, Yu J, Valerius MT, Georgas K, Chiu HS, Brennan J, Armstrong J, Little MH, McMahon AP, Southard-Smith EM (2012) A genome-wide screen to identify transcription factors expressed in pelvic ganglia of the lower urinary tract. Front Neurosci 6:130
24. Online Mendelian Inheritance in Man (OMIM). Available at: http://www.ncbi.nlm.nih.gov/omim. Accessed 22 May 2013
25. Holmlund C, Nilsson J, Guo D, Starefeldt A, Golovleva I, Henriksson R, Hedman H (2004) Characterization and tissue-specific expression of human LRIG2. Gene 332:35-43
26. Guo D, Holmlund C, Henriksson R, Hedman H (2004) The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 84:157-165
27. Homma S, Shimada T, Hikake T, Yaginuma H (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 9:1-26
28. Gur G, Rubin C, Katz M, Amit I, Citri A, Nilsson J, Amariglio N, Henriksson R, Rechavi G, Hedman H, Wides R, Yarden Y (2004) LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 23:3270-3281
29. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, Carraway KL III, Sweeney C (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem 279:47050-47056
30. Wang Y, Poulin EJ, Coffey RJ (2013) LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. Br J Cancer 108:1765-1770
31. Zhang Y, Yeung MN, Liu J, Chau CH, Chan YS, Shum DK (2006) Mapping heparanase expression in the spinal cord of adult rats. J Comp Neurol 494:345-357
32. Navarro FP, Fares RP, Sanchez PE, Nadam J, Georges B, Moulin C, Morales A, Pequignot JM, Bezin L (2008) Brain heparanase expression is up-regulated during postnatal development and hypoxia-induced neovascularization in adult rats. J Neurochem 105:34-45
33. Cui H, Shao C, Liu Q, Yu W, Fang J, Yu W, Ali A, Ding K (2011) Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway. Biochem J 440:273-282
34. Holmlund C, Haapasalo H, Yi W, Raheem O, Brännström T, Bragge H, Henriksson R, Hedman H (2009) Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology 29:242-247
35. Wang B, Han L, Chen R, Cai M, Han F, Lei T, Guo D (2009) Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol Ther 8:1018-1023
36. Al Mosawi AJ (2007) Identification of nonneurogenic neurogenic bladder in infants. Urology 70:355-356
37. Vidal I, Héloury Y, Ravasse P, Lenormand L, Leclair MD (2009) Severe bladder dysfunction revealed prenatally or during infancy. J Pediatr Urol 5:3-7
38. Silay MS, Tanriverdi O, Karatag T, Ozcelik G, Horasanli K, Miroglu C (2011) Twelve-year experience with Hinman-Allen syndrome at a single center. Urology 78:1397-1401
39. Yeung CK, Godley ML, Dhillon HK, Duffy PG, Ransley PG (1998) Urodynamic patterns in infants with normal lower urinary tracts or primary vesico-ureteric reflux. Br J Urol 81:461-467
40. Karami H, Razi A, Mazloomfard MM, Javanmard B (2012) Is there any role for urodynamic study in children with high-grade vesicoureteral reflux? Urology 79:888-891
41. Hufton AL, Vinayagam A, Suhai S, Baker JC (2006) Genomic analysis of Xenopus organizer function. BMC Dev Biol 6:27
42. McKenzie EA (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151:1-14
43. Courtney SM, Hay PA, Buck RT, Colville CS, Phillips DJ, Scopes DI, Pollard FC, Page MJ, Bennett JM, Hircock ML, McKenzie EA, Bhaman M, Felix R, Stubberfield CR, Turner PR (2005) Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett 15:2295-2299
44. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, Okada Y, Seimiya H, Fusaki N, Hasegawa M, Fukuda K (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14